Crohn's disease

G Roda, S Chien Ng, PG Kotze, M Argollo… - Nature Reviews …, 2020 - nature.com
Crohn's disease is an inflammatory bowel disease that is characterized by chronic
inflammation of any part of the gastrointestinal tract, has a progressive and destructive …

Newer biologic and small-molecule therapies for inflammatory bowel disease

DC Baumgart, C Le Berre - New England Journal of Medicine, 2021 - Mass Medical Soc
Newer Biologic and Small-Molecule Therapies for IBD There is still no cure for inflammatory
bowel disease. This review covers newer treatments that reflect our understanding of the …

ECCO guidelines on therapeutics in ulcerative colitis: medical treatment

T Raine, S Bonovas, J Burisch… - Journal of Crohn's …, 2022 - academic.oup.com
Ulcerative colitis [UC] is a chronic inflammatory bowel disease [IBD] characterised by colonic
inflammation extending to a variable extent from the rectum. Care of the patient with UC …

ECCO guidelines on therapeutics in Crohn's disease: medical treatment

J Torres, S Bonovas, G Doherty… - Journal of Crohn's …, 2020 - academic.oup.com
2. Methods Based on the GRADE workflow, the Guidelines Committee of ECCO [GuiCom]
selected a panel of 48 experts supported by a team of methodologists and librarians …

[HTML][HTML] Shared decision-making in the management of patients with inflammatory bowel disease

K Song, D Wu - World journal of gastroenterology, 2022 - ncbi.nlm.nih.gov
The rapid progress of research into inflammatory bowel disease (IBD) has resulted in
increasingly more treatment options. Different options have different advantages and …

Colon‐Targeted Adhesive Hydrogel Microsphere for Regulation of Gut Immunity and Flora

H Liu, Z Cai, F Wang, L Hong, L Deng… - Advanced …, 2021 - Wiley Online Library
Intestinal immune homeostasis and microbiome structure play a critical role in the
pathogenesis and progress of inflammatory bowel disease (IBD), whereas IBD treatment …

ECCO guidelines on therapeutics in Crohn's disease: surgical treatment

M Adamina, S Bonovas, T Raine… - Journal of Crohn's …, 2020 - academic.oup.com
This article is the second in a series of two publications relating to the European Crohn's and
Colitis Organisation [ECCO] evidence-based consensus on the management of Crohn's …

Natural disease course of Crohn's disease during the first 5 years after diagnosis in a European population-based inception cohort: an Epi-IBD study

J Burisch, G Kiudelis, L Kupcinskas, HAL Kievit… - Gut, 2019 - gut.bmj.com
Objective The Epi-IBD cohort is a prospective population-based inception cohort of
unselected patients with inflammatory bowel disease from 29 European centres covering a …

Optimizing biologic therapy in IBD: how essential is therapeutic drug monitoring?

M Argollo, PG Kotze, P Kakkadasam… - Nature Reviews …, 2020 - nature.com
Proposed treatment targets for the management of inflammatory bowel disease (IBD) have
moved beyond symptomatic improvement towards more objective end points, such as …

The role of TNF-α and anti-TNF-α agents during preconception, pregnancy, and breastfeeding

K Romanowska-Próchnicka, A Felis-Giemza… - International journal of …, 2021 - mdpi.com
Tumor necrosis factor-alpha (TNF-α) is a multifunctional Th1 cytokine and one of the most
important inflammatory cytokines. In pregnancy, TNF-α influences hormone synthesis …